Student Theses and Dissertations
Date of Award
2024
Document Type
Thesis
Degree Name
Doctor of Philosophy (PhD)
RU Laboratory
Casanova Laboratory
Abstract
Tuberculosis (TB), a multi-organ infectious disease caused by virulent mycobacteria, most predominantly M. tuberculosis, remains one of the deadliest infectious diseases in human history. Bacillus Calmette-Guérin (BCG) vaccine, first implemented medically in1921, has remained the only available vaccine for TB, although its protective effect is moderate.TB occurs in 5-10% of individuals exposed to those pathogens, while 90-95% remain asymptomatic (i.e.,latent infection or spontaneous clearance). This surprisingly large inter-individual variability has long attracted the attention of human geneticists. Classical twin-based genetic studies have demonstrated the presence of a substantial genetic risk of developing TB disease between monozygotic twins. Later, the clinical and genetic characterization of a rare and severe disease caused by weakly virulent and normally harmless mycobacteria, such as the BCG vaccine substrain, now recognized as Mendelian Susceptibility to Mycobacterial Disease (MSMD), demonstrated that IFN-γ is indispensable for antimycobacterial immunity in humans.Moreover, homozygosity for a common missense mutation P1104A in a protein TYK2 was discovered as the first genetic predisposing factor to TB in humans. TYK2 P1104A selectively impairs IL-23-dependent IFN-γ production by lymphocytes.In light of these findings, I hypothesized that a partial impairment of IFN-γ immunity due to known or novel genetic defects underlies vulnerability to TB in humans. I characterized three rare genetic etiologies of TB in children and young adults: inherited ITK, PD-1, and LY9 deficiencies.These rare genetic defects partially impair IFN-γ production by diverse T cell subsets through distinct mechanisms such as development, exhaustion, and epigenetic imprinting.Thus, the first part of my graduate research demonstrates that even partial impairment of T-cell IFN-γ production can underlie TB in young humans. PD-1 is an inhibitory “checkpoint” in T lymphocytes ligated with two known ligands, PD-L1andPD-L2, to maintain self-tolerance.The PD-1-deficient proband had not only TB but also multi-organ autoimmunity and died of autoimmune pneumonitis at age 11 years.His older brother also had type 1 diabetes and died of pneumonitis of undocumented etiology at age 3 years.Moreover,I had an opportunity to study another two siblings with inheritedPD-L1 deficiency, both of whom had early-onset type 1diabetes. Unlike the two PD-1-deficient siblings,neither of the PD-L1-deficient siblings developed any autoimmune phenotypes other than endocrinological autoimmunity. Consistent with their much more severe clinical manifestations, PD-1 deficiency triggered much more severe leukocyte dysregulation than PD-L1 deficiency.The discordant severity in clinical and leukocytic phenotypes in humans with PD-1 and PD-L1 deficiencies suggest that 1) PD-1:PD-L2 interaction can compensate, at least in part,for the absence of PD-1:PD-L1 signal to mitigate unrestrained leukocytic dysregulation in vivo; and that 2) PD-1:PD-L1 signal is nonetheless indispensable in preventing type 1 diabetes in humans. Finally, during these studies, I discovered that PD-1 and PD-L1contribute to optimal memory B cell development and antibody responses.Surprisingly, PD-1:PD-L1 interactions promote immunoglobulin production in a B-cell-autonomous manner,and a newly established B-cell-specific PD-1 KO mouse line showed a severe contraction of almost all B cell compartments. In fact, the B-cell phenotype was much more severe in B-cell-specific PD-1 KO mice than in whole-body KO mice, suggesting that1) PD-1 on B cells has a critically indispensable role in the homeostasis of B cells and 2) PD-1 on leukocytes other than B cells (probably T cells) has a unique role in mitigating the disturbance the B-cell compartment.Thus, the second part of my graduate research provides unique insights into the non-redundant roles of PD-1 and PD-L1 in maintaining self-tolerance and functional oral immunity in mice and humans.
Recommended Citation
Ogishi, Masato, "Human Inborn Errors of Immunity: Tuberculosis, Autoimmunity, and Beyond" (2024). Student Theses and Dissertations. 770.
https://digitalcommons.rockefeller.edu/student_theses_and_dissertations/770
Comments
A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy